Through impacts on GSH and MDA levels that alter the release of inflammatory factors and, therefore, lung damage, it is possible to explain the relationship between annexin A1, sRAGE, and COPD. This evidence concerns the gene ANXA1 and chronic obstructive pulmonary disease.